Fundraising FoxWuXi Healthcare Ventures — Full Portfolio
6 tracked investments · listed companies and verified rows first
IDEAYA is a precision medicine oncology company developing first-in-class targeted therapies and rational drug combinations for molecularly defined, hard-to-treat cancers.
BiotechDigital HealthHealthtechMedical DevicesSouth San Francisco, US
Paul Stone(Executive Officer)inYujiro S. Hata(President, Chief Executive Officer and Director)
BoardTimothy Shannon(Director)inJohn Diekman(Director)inTerry Rosen(Director)Jeffrey Stein(Director)
Co-investors5AM VenturesCanaan PartnersGV (Google Ventures)Nextech InvestBiotechnology Value Fund
23andMe operates a research platform that collects genetic data from millions of users to advance genomic research and health discovery.
BiotechDigital HealthDirect to ConsumerHealthtechLongevityMountain View, US
Anne Wojcicki(Founder)inLinda Avey(Founder)Paul Cheung(Co-founder)Andrew Page(Executive Officer, Director)Kathy Hibbs(Executive Officer)inPaul Cusenza(Founder)
Co-investorsAdam NashAllied Venture PartnersCivilization Ventures Management, LlcEQUIAMFirebolt Ventures Management Company, LlcG Squared+17 more
BiotechSan Diego, US
Francois Ferre(Director)Magda Marquet(Director)Jorge Garces(Executive Officer)inGreg Hamilton(Executive Officer, Director)Carin Sandvik(Executive Officer)Jeffrey G. Black(Executive Officer)
Co-investorsBioBritTelegraph Hill PartnersAlly Bridge GroupVivo Capital
Hong Kong-listed (HKEX: 2616) Chinese biopharmaceutical company developing oncology, immunology and inflammation therapies.
Co-investorsARCH Venture Partners6 Dimensions CapitalBoyu CapitalGICHillhouse Capital
Ivenix makes an intelligent infusion pump system for hospital settings that delivers intravenous medications to patients while incorporating safeguards to reduce medication errors.
BiotechHealthtechMedical DevicesAmesbury, US
John Sokolowski(Executive Officer)inGeorge W. Gray(Executive Officer)Carolyn Malleck(Executive Officer)inJesse Ambrosina(Executive Officer)
BoardKetan Patel(Director)inJohn K. Clarke(Director)in
Co-investorsCardinal PartnersF-Prime CapitalSCP Vitalife PartnersECO Fleet Holdings
LifeMine is a biopharmaceutical company that uses data science and advanced methods to accelerate drug discovery and develop precision medicines across therapeutic areas.
AI & Machine LearningBiotechDeep TechCambridge, US
Gregory L. Verdine(Executive Officer, Director)Gregory Verdine, Ph.D.
BoardHingge Hsu(Executive Officer, Director)Weiqing Zhou(Executive Officer, Director)
Co-investorsARCH Venture PartnersGV (Google Ventures)RA CapitalAisling CapitalAlexandriaBezos Expeditions+7 more
BiotechMenlo Park, US
Cuiping Gu(Director)David Parkinson(Director)inZhenping Zhu(Director)Karen Liu(Director)Bing C. Wang(Executive Officer, Director)
Co-investorsDanhua CapitalSangel CapitalShangBay Capital LLC
Syros Pharmaceuticals is a Massachusetts gene-control biotech developing small molecules that regulate disease gene expression.
Cambridge, US
Nancy Simonian(CEO)
Co-investorsAisling CapitalARCH Venture PartnersQuan CapitalAlexandriaAlly Bridge GroupBain Capital+11 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.